Pediatrics, Pediatric Hematology-Oncology · Durham, NC
NPI
1538161245
Since 2005
Specialty
Pediatrics, Pediatric Hematology-Oncology
Code 2080P0207X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
40 Duke Medicine Cir # 2n
Durham, NC, 27710
Phone (919) 684-0628
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
230 services
Medicare patients, 2024
113
Average age 63
Drug cost, 2024
$1.0M
515 prescriptions
Company payments, 2025
$18K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John J Strouse was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 64 times for 49 patients. In total John J Strouse billed 230 services in 16 codes, and Medicare paid $13K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 64 | 49 | $11.54 | $739 |
| 99215 Office E&M - Established | Facility | 32 | 26 | $100.11 | $3,203 |
| 99232 Hospital E&M - Subsequent | Facility | 32 | 23 | $54.92 | $1,757 |
| 99214 Office E&M - Established | Facility | 29 | 25 | $65.20 | $1,891 |
| 99222 Hospital E&M - Initial | Facility | 23 | 23 | $92.79 | $2,134 |
| 99204 Office E&M - New | Facility | 14 | 14 | $84.67 | $1,185 |
By year: 2022 $12K for 157 services; 2023 $13K for 163 services; 2024 $13K for 230 services.
Medicare prescription drug claims, 2024
In 2024, the drug John J Strouse prescribed most often to Medicare patients was Hydroxyurea, with 200 prescriptions and refills. In total John J Strouse wrote 515 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 200 | 285 | 49 | $6,269 |
| Oxycodone Hcl Generic | 55 | 55 | 26 | $710 |
| Morphine Sulfate Er Morphine Sulfate | 27 | 27 | Under 11 | $886 |
| Ferriprox (2 Times A Day) Deferiprone | 26 | 26 | Under 11 | $712K |
| Eliquis Apixaban | 22 | 42 | Under 11 | $24K |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 21 | 21 | Under 11 | $518 |
| Duloxetine Hcl Generic | 19 | 25 | Under 11 | $278 |
| Gabapentin Generic | 17 | 17 | Under 11 | $393 |
| Oxbryta Voxelotor | 12 | 12 | Under 11 | $143K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 11 | 11 | Under 11 | $251 |
Brand drugs: 95 claims; generic drugs: 420 claims; opioid claims: 117.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John J Strouse $18K ($18K in general payments such as food, travel and fees) from 5 companies. The largest payer was Octapharma USA, Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| Octapharma USA, Inc. | 5 | $17K |
| Biocodex, Inc. | 1 | $700 |
| Novo Nordisk Inc NVO | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.